- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Repaglinide, Bupropion and SHR3680
Total 488 results
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Jiangsu HengRui Medicine Co., Ltd.CompletedGout and HyperuricemiaChina
-
Dalim BioTech Co., Ltd.CompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Novo Nordisk A/SCompleted
-
Jiangsu HengRui Medicine Co., Ltd.UnknownProstate Cancer | Castration-resistant Prostate CancerChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Boehringer IngelheimCompleted
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingHepatic Impairment | Healthy ParticipantsChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesKorea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesKorea, Republic of
-
Children's Hospital of PhiladelphiaWithdrawn
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Arbelaez, Ana MariaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Novo... and other collaboratorsCompletedPancreatic Insufficiency | Cystic Fibrosis Related DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSpain
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTurkey
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMalaysia, Thailand, China, Philippines
-
Steno Diabetes Center CopenhagenCompletedDiabetes Mellitus, Type 2Denmark
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesLuxembourg, Belgium
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingPatients With High-risk Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical ProstatectomyChina
-
Jiangsu HengRui Medicine Co., Ltd.UnknownProstate Cancer MetastaticChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesBelgium
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Boehringer IngelheimNot yet recruiting
-
Chinese PLA General HospitalUnknown
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMalaysia, South Africa, Hong Kong, Taiwan, Philippines
-
Steno Diabetes Center CopenhagenCompletedDiabetes Mellitus, Type 2Denmark
-
National Cheng-Kung University HospitalUnknown
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
National Institute of Diabetes and Digestive and...Novo Nordisk A/S; Cystic Fibrosis FoundationCompletedDiabetes Mellitus | Cystic FibrosisUnited States, Canada
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHormone Sensitive Prostate CancerChina
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesGreece
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingHepatic ImpairmentChina
-
Jiangsu HengRui Medicine Co., Ltd.UnknownHepatic Impairment | Healthy Participants
-
Eli Lilly and CompanyLoxo Oncology, Inc.CompletedHealthyUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
RenJi HospitalCompletedDiabetes Mellitus, Type 2China
-
Atridia Pty Ltd.CompletedHyperuricemia | GoutAustralia
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingPrimary Gout and Hyperuricemia
-
Deciphera Pharmaceuticals LLCActive, not recruitingGIST - Gastrointestinal Stromal TumorUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Enrolling by invitationHormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage,Female Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Jiangsu HengRui Medicine Co., Ltd.RecruitingProstate Cancer | Biochemical RecurrenceChina